tbuckley/cabot-search huggingface dataset:
Experts debate food stamp revision
Authors: A. A. Skolnick
Journal: JAMA (1995)

IF POOR PEOPLE can't buy enough food to eat, let them eat food supplements. So says a bill before Congress that would allow those who receive food stamps to use them for buying vitamins and minerals. While supported by the food supplement industry and a minority of nutrition experts, the move to change the US Department of Agriculture (USDA) Food Stamp Program is opposed by many health leaders and organizations that monitor hunger in the nation's children. Among the opposition are the American Academy of Pediatrics, American Heart Association (AHA), USDA, and Food Research and Action Center, a national, not-for-profit organization dedicated to eliminating hunger and under-nutrition in the United States. Proponents of House bill HR 1997 (formerly HR 236)—which seeks to amend the definition of food in the Food Stamp Act of 1977 to include vitamin and mineral supplements—argue that, in the interest of better health, poor people should
Herpes Simplex: Idurine and Corticosteroids
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Annals Graphic Medicine: Introducing “Dr. Mom” and “Progress Notes”
Journal: Annals of Internal Medicine (2019)

Editorials19 February 2019Annals Graphic Medicine: Introducing “Dr. Mom” and “Progress Notes”The EditorsThe EditorsSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M19-0058 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Annals Graphic Medicine (http://annals.org/graphicmedicine) brings together original graphic narratives, comics, animation, and other creative forms by those who provide or receive health care. They address medically relevant topics—be they poignant, thought-provoking, or just plain entertaining. Launched in 2015, the series has included single-image artwork; multipaneled sequential stories; and videos from clinicians, patients, and caregivers.The ever-growing popularity of Annals Graphic Medicine has prompted us to expand it to include regular monthly features from 2 talented physician artists. “Dr. Mom” by Grace Farris, MD, explores the challenges and ups and downs of juggling life as a hospitalist and mother. “Progress Notes” ... Author, Article, and Disclosure InformationAffiliations: This article was published at Annals.org on 5 February 2019. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAnnals Graphic Medicine - Dr. Mom: Doing It All Grace E. Farris Annals Graphic Medicine - Dr. Mom: Doing It All Grace E. Farris Annals Graphic Medicine - Progress Notes: Cancer Michael Natter Metrics Cited byLa historia del conocimiento. Utilización del cómic en una revista científica 19 February 2019Volume 170, Issue 4Page: 268KeywordsCaregiversHealth careHospitalists ePublished: 5 February 2019 Issue Published: 19 February 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
A dose of Spanish fly
Authors: A. J. Presto
Journal: JAMA (1970)

Acute cantharides intoxication, characterized by crampy abdominal pain, diarrhea, hematemesis, increased urinary frequency, dysuria, hematuria, and the appearance of blisters, was treated with intravenous fluid therapy and supportive care. Since our patient easily obtained his dose at a hippie gathering, we may encounter such poisonings more frequently.
Beitrage zur Entwicklungsgeschichte der menschlichen Gehirns.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE MEDICAL MAN AND HIS MORALS.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Coagulopathy associated with vitamin E ingestion
Authors: J. J. Corrigan
Journal: JAMA (1974)

Although hypervitaminosis E causes a prolonged prothrombin time and a hemorrhagic state in animals, excessive vitamin E has not previously been found to cause bleeding in normal humans. We have seen a prolonged prothrombin time and ecchymoses develop in a patient who was taking warfarin sodium and clofibrate concomitant with self-administration of vitamin E. The prothrombin time returned to base line after vitamin E ingestion was stopped while warfarin and clofibrate treatment was continued. Coagulation studies demonstrated enhanced reduction of the levels of vitamin K-dependent coagulation factors during the period of vitamin E ingestion, which returned to base-line levels after the patient stopped taking the vitamin. Plasma warfarin levels did not change and platelet function remained normal. The data suggest that patients with vitamin K deficiency may risk hemorrhage if they take vitamin E. (<i>JAMA</i>230:1300-1301, 1974)
EFFECT OF PREGNANCY ON SYSTEMIC LUPUS ERYTHEMATOSUS
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma
Authors: E. L. Bravo
Journal: Endocrine Reviews (1994)

THE very first known successful operation for removal of a pheochromocytoma was performed by Cesar Roux in February 1926 in Lausanne, Switzerland (1). C. H. Mayo performed the first successful removal of a pheochromocytoma in North America in October of the same year (2). Since these first successful operations, considerable progress has been made in the diagnosis and treatment of pheochromocytoma. The availability of sensitive and specific immunoassay procedures, the development of simplified diagnostic testing, and the introduction of sensitive imaging techniques have enhanced the clinician's ability to make the diagnosis with greater certainty. In addition, a better understanding of catecholamine action and the pathophysiology of pheochromocytoma and an appreciation of the wide range of clinical manifestations associated with it have led not only to earlier recognition of the disease but also to a more rational approach to its diagnosis and management. Nevertheless, there are still uncertainties regarding the pathophysiology of hypertension, about optimal screening methods, the sensitivity and specificity of the various diagnostic tests, the diagnostic process, and the approach to treatment.
Cholesteatoma
Authors: Robert W. Cantrell
Journal: JAMA (1977)

One of the enigmas in otolaryngology is how a small epidermal inclusion cyst in the middle ear or mastoid can create such a giant problem in management. Another enigma is how a relatively small place like Iowa City can produce such a giant clinical and academic program. The list of outstanding clinicians, academicians, and researchers who passed through this outstanding program reads like a<i>Who's Who of Otolaryngology</i>. Much of the credit for this must go to the organizational genius of the late Dean Lierle who not only shaped the program at the University of Iowa, but also assisted in charting the course of otolaryngology from its nadir in the early 1950s to its position of prominence today. That Iowa City could host the First International Conference of Cholesteatoma is a tribute to Lierle and his able successor, Brian McCabe. Assisting Dr McCabe in organizing this conference were his former
Osimertinib Treats CNS Metastases in NSCLC
Journal: Cancer Discovery (2018)

The EGFR inhibitor osimertinib may be an effective therapy for patients with untreated non-small cell lung cancer who have brain metastases. In a recent study, the drug extended median progression-free survival and increased objective response rates compared with the first-generation EGFR inhibitors gefitinib and erlotinib.
&lt;TITLE&gt;A Healthy Diet&lt;/TITLE&gt;
Journal: JAMA (2000)

and the AMA.The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis.For specific information concerning your personal medical condition, JAMA and the AMA suggest that you consult your physician.This page may be reproduced noncommercially by physicians and other health care professionals to share with patients.Any other reproduction is subject to AMA approval.
Skin Tags and Colonic Polyps
Authors: KATHY J. FLEGEL
Journal: Annals of Internal Medicine (1984)

Letters and Corrections1 January 1984Skin Tags and Colonic PolypsKATHY J. FLEGEL, M.D., PATRICK M. DUNN, M.D., ROBERT W. BENTLEY, M.D., MARK N. MILLER, M.D.KATHY J. FLEGEL, M.D.Search for more papers by this author, PATRICK M. DUNN, M.D.Search for more papers by this author, ROBERT W. BENTLEY, M.D.Search for more papers by this author, MARK N. MILLER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-100-1-159_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: We reviewed "Skin Tags: A Cutaneous Marker for Colonic Polyps" by Leavitt and associates (1) in the June issue and found it to have little clinical usefulness. The authors conclude that the sensitivity and specificity of skin tags serving as cutaneous markers for adenomatous colonic polyps are both greater than 75%. In patients referred for colonoscopy, they believe that skin tags may be a means of identifying patients with an increased risk of colonic polyps. The authors suggest that a prospective study is needed to ascertain whether the same conclusion holds true for asymptomatic patients.The presence...References1. LEAVITTKLEINKENDRICKSGAVALERVAN THIEL JIFJD. Skin tags: a cutaneous marker for colonic polyps. Ann Intern Med. 1983;98:928-30. LinkGoogle Scholar2. HAYNES R. How to read clinical journals: II. To learn about a diagnostic test. Can Med Assoc J. 1981;124:703-10. MedlineGoogle Scholar1. KLEINPARVEENGAVALERVAN THIEL IGJD. Colonic polyps in patients with acromegaly. Ann Intern Med. 1982;97:27-30. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Good Samaritan Hospital and Medical Center Portland, OR 97210 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByCutaneous manifestations of gastrointestinal disorders. Part IGastrointestinal Polyposis SyndromesMelanoma, Growth Factors, and Cutaneous Paraneoplastic SyndromesAssociation between acrochordons and colonic polypsSkin Tags and Colonic PolypsWENDY LEVINSON, M.D., PATRICK M. DUNN, M.D. 1 January 1984Volume 100, Issue 1Page: 159-160KeywordsColonoscopyProspective studiesSpecificity Issue Published: 1 January 1984 PDF DownloadLoading ...
Community medicine: a second chance?
Authors: J R Wood
Journal: BMJ (1980)

The effects and potential recovery of aquatic plant Lemna gibba exposed to a sulfonyl urea herbicide metsulfuron-methyl (MSM) for 120 days under rice cropping condition was investigated. The frond number was decreased by day 15 at the concentration 11 µg/L and 100% inhibition on growth rate of Lemna was observed. Continuous decrease of frond number by day 50 at below the detectable level of residues exhibited symptoms (chlorosis) of MSM toxicity. Toxicity was assessed on the basis of toxicity index (TI) value, growth rate, yield and pigment contents (chlorophyll, carotene, total carotenoid and xanthophyll) of treated samples compared with untreated control. The observed value of 0.698 µg/g chlorophyll a, 0.263 µg/g chlorophyll b, 0.147 µg/g carotene, 1.620 µg/g total carotenoid and 1.473 µg/g xanthophyll contents in treated samples was statistically significantly different from control value of 4.366 µg/g chlorophyll a, 3.132 µg/g chlorophyll b, 0.796 µg/g carotene, 17.755 µg/g total carotenoid and 16.937 µg/g xanthophyll contents by day 50 samples. After prolonged exposure, growth rate, yield and pigment content for the treated samples recovered to control levels on day 120. The obtained data indicate the application of aquatic plant Lemna gibba as sensitive biomarker of water quality as well as the significance of selected biological parameters in the reliable assessment of toxic potential of MSM under rice cropping condition.
Software
Authors: Erin G. Stone
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dr. Turecki and Colleagues Reply
Authors: GUSTAVO TURECKI, RICHARD BRIÈRE, KAREN DEWAR, ALAIN D. LESAGE, MONIQUE SÉGUIN, NADIA CHAWKY, CLAUDE VANIER, MARTIN ALDA, RIDHA JOOBER, CHAWKI BENKELFAT, GUY A. ROULEAU
Journal: American Journal of Psychiatry (2001)
A phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant, metastatic prostate cancer.
Authors: Akash Patnaik, Massimo Loda, Justin Kung, Jim Wu, Mary-Ellen Taplin, Philip W. Kantoff, Lewis Cantley, Steven P. Balk, Glenn J. Bubley
Journal: Journal of Clinical Oncology (2014)

TPS2641 Background: There is significant cross-talk between PI3-kinase (PI3K) pathway and androgen receptor (AR) signaling pathways, respectively, which are both critical for cell survival in castrate-resistant prostate cancer (CRPC). The primary study objective is to determine the safety profile and maximum tolerated dose (MTD) of BKM120 (pan-PI3K inhibitor) in combination with abiraterone/prednisone (A/P) in CRPC patients. The secondary study objectives are to assess the impact of PTEN status on duration of response/time to progression in the expansion cohort, and to evaluate the impact of BKM120 on a PI3-kinase activation fingerprint in metastatic bone or lymph node tissue samples. An exploratory objective of the study is to assess the effect of BKM120 on transcription of a set of AR-regulated genes in metastatic bone biopsy samples. Methods: The trial design involves a 14 day lead-in phase with BKM120 alone, to assess single-agent toxicity and perform correlative studies. A/P is combined with BKM120 at the end of 14 days using the standard 3+3 dose-escalation design with 3 dose levels of BKM120 (80 mg, 100 mg, 120 mg, respectively), and participants are assessed for safety and MTD on the combination therapy. The MTD dose will be used in the expansion cohort to assess safety of the combination. To determine pharmacodynamic impact of single agent BKM120 on the PI3K activation signature at a metastatic site, a mandatory CT-guided bone or lymph node biopsy is performed prior to BKM120 initiation and at the end of 2 weeks on BKM120 single-agent therapy. Immunohistochemical (IHC) stains for four markers (p-AKT, p-S6, PTEN and stathmin) are used to obtain a PI3K activation score, based on the quartile levels of continuous staining scores of each marker. Clinical trial information: NCT01741753.
Spinal Pumping
Authors: L. R. Jury
Journal: BMJ (1947)

Forty-three ASA physical status I and II patients, scheduled for elective urologic surgery, were randomly entered into a randomized double-blind study using 20 ml bupivacaine 0.75% or 20 ml ropivacaine 0.75%, both with 5 μg/ml epinephrine. Two patients were excluded from evaluation of efficacy due to technical failure. After a test dose of 3 ml bupivacaine 0.75% with epinephrine or ropivacaine 0.75% with epinephrine, 17 ml of either solution was given in incremental doses over 4 minutes (4, 4, 4, and 5 ml). Analgesia was satisfactory for surgery in all patients except for one in each group. The onset time of analgesia was short: after administration of ropivacaine and bupivacaine, the T12 dermatome was blocked within 6-8 minutes. Mean maximum upper level of analgesia was similar in the groups—T8 ± 0.6 and T7 ± 0.6 (mean ± SEM)—for ropivacaine and bupivacaine, respectively. Duration of analgesia at the T10 level was 190 ± 12 minutes in the ropivacaine group and 234 ± 20 minutes in the bupivacaine group and was significantly shorter for ropivacaine at T10, L2, and S5 segments. Frequency of complete motor block was significantly lower in the ropivacaine group (7/21) than in the bupivacaine group (16/20). No differences were found in onset to various degrees of motor block, however, the duration of degree 1 motor block was significantly shorter in the ropivacaine group. Hypotension and bradycardia requiring treatment were experienced by seven and three patients, respectively, in the bupivacaine group, and by two and one patient, respectively, in the ropivacaine group. No postoperative adverse events related to anesthesia were observed. Ropivacaine 0.75% with epinephrine is an effective long-acting local anesthetic. Duration of sensory block is similar to that of bupivacaine 0.75% with epinephrine; however, the motor block is less profound and of shorter duration.
Transplacental Passage of Fetal Red Blood Cells and Pathogenesis of Rh Immunization During Pregnancy
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal